Overview

Neoadjuvant Treatment for Advanced Rectal Carcinoma

Status:
Active, not recruiting
Trial end date:
2030-08-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to compare pre-operative radio-chemotherapy (RT + capecitabine) to a short course RT associated with a delayed surgery, with two primary objectives: the efficacy evaluation (rate of R0 resection) and the preservation of autonomy (score IADL).
Phase:
Phase 3
Details
Lead Sponsor:
UNICANCER
Treatments:
Capecitabine